 |
humanized IgG4 monoclonal antibody against total complement component 1, subcomponent s (C1s) |
|---|---|
| Trade Name | |
| Orphan Indication | Autoimmune hemolytic anemia |
| USA Market Approval | USA |
| USA Designation Date | 2016-07-27 00:00:00 |
| Sponsor | Bioverativ USA, Inc.;951 Gateway Boulevard;South San Francisco, California, 94080 |
